Product Images Vaxelis

DTaP-IPV-Hib-HepB is a vaccine for children between 6 weeks and 4 years, consisting of a single-dose injection of 0.5 mL administered via intramuscular route. The vaccine provides protection against Diphtheria and Tetanus Toxoids, Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate, and Hepatitis B. The vaccine is commercially available as Vaxelis® R and is manufactured by Sanofi Pasteur Limited.*

This appears to be a vaccine package insert, providing information about the ingredients, dosage, and administration for a combination vaccine for Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate, and Hepatitis B. The text includes warnings to shake the vaccine well before use, discard unused portions, and protect from light. The specific dosages and antigen types are listed, along with the age range for administration and prescribing information.*

This is a description of a vaccine called Vaxelis. It is a combined vaccine for different diseases such as Diphtheria, Tetanus, Pertussis, Poliovirus, Haemophilus b, and Hepatitis B. The vaccine is administered as a single dose of 0.5mL for infants aged 6 weeks to a few years. The vaccine is manufactured by Sanofi Pasteur Limited with product code NDC 63361-243-88.*

This is a packaging label for a vaccine called Vaxelis, intended to protect against diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus b Conjugate and hepatitis B. It contains details such as the storage temperature, dosage, and components in the vaccine. The vaccine is manufactured by Merck Sharp and Dohme Corp, a subsidiary unit of Merck & Co. It also includes additional information and instructions for use.*